249 related articles for article (PubMed ID: 11851733)
1. Spasticity versus strength in cerebral palsy: relationships among involuntary resistance, voluntary torque, and motor function.
Damiano DL; Quinlivan J; Owen BF; Shaffrey M; Abel MF
Eur J Neurol; 2001 Nov; 8 Suppl 5():40-9. PubMed ID: 11851733
[TBL] [Abstract][Full Text] [Related]
2. Relationship of spasticity to knee angular velocity and motion during gait in cerebral palsy.
Damiano DL; Laws E; Carmines DV; Abel MF
Gait Posture; 2006 Jan; 23(1):1-8. PubMed ID: 16311188
[TBL] [Abstract][Full Text] [Related]
3. Identification of the neural component of torque during manually-applied spasticity assessments in children with cerebral palsy.
Bar-On L; Desloovere K; Molenaers G; Harlaar J; Kindt T; Aertbeliën E
Gait Posture; 2014 Jul; 40(3):346-51. PubMed ID: 24931109
[TBL] [Abstract][Full Text] [Related]
4. No change in calf muscle passive stiffness after botulinum toxin injection in children with cerebral palsy.
Alhusaini AA; Crosbie J; Shepherd RB; Dean CM; Scheinberg A
Dev Med Child Neurol; 2011 Jun; 53(6):553-8. PubMed ID: 21574991
[TBL] [Abstract][Full Text] [Related]
5. Neuro-musculoskeletal simulation of instrumented contracture and spasticity assessment in children with cerebral palsy.
van der Krogt MM; Bar-On L; Kindt T; Desloovere K; Harlaar J
J Neuroeng Rehabil; 2016 Jul; 13(1):64. PubMed ID: 27423898
[TBL] [Abstract][Full Text] [Related]
6. Spasticity and strength changes as a function of selective dorsal rhizotomy.
Engsberg JR; Olree KS; Ross SA; Park TS
J Neurosurg; 1998 Jun; 88(6):1020-6. PubMed ID: 9609297
[TBL] [Abstract][Full Text] [Related]
7. Botulinum toxin for spasticity in children with cerebral palsy: a comprehensive evaluation.
Bjornson K; Hays R; Graubert C; Price R; Won F; McLaughlin JF; Cohen M
Pediatrics; 2007 Jul; 120(1):49-58. PubMed ID: 17606561
[TBL] [Abstract][Full Text] [Related]
8. Roles of reflex activity and co-contraction during assessments of spasticity of the knee flexor and knee extensor muscles in children with cerebral palsy and different functional levels.
Pierce SR; Barbe MF; Barr AE; Shewokis PA; Lauer RT
Phys Ther; 2008 Oct; 88(10):1124-34. PubMed ID: 18703677
[TBL] [Abstract][Full Text] [Related]
9. Neurorehabilitation with versus without resistance training after botulinum toxin treatment in children with cerebral palsy: a randomized pilot study.
Bandholm T; Jensen BR; Nielsen LM; Rasmussen H; Bencke J; Curtis D; Pedersen SA; Sonne-Holm S
NeuroRehabilitation; 2012; 30(4):277-86. PubMed ID: 22672941
[TBL] [Abstract][Full Text] [Related]
10. Estimation of botulinum toxin type A efficacy on spasticity and functional outcome in children with spastic cerebral palsy.
Colovic H; Dimitrijevic L; Stankovic I; Nikolic D; Radovic-Janosevic D
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2012 Mar; 156(1):41-7. PubMed ID: 22580859
[TBL] [Abstract][Full Text] [Related]
11. Instrumented assessment of the effect of Botulinum Toxin-A in the medial hamstrings in children with cerebral palsy.
Bar-On L; Aertbeliën E; Molenaers G; Van Campenhout A; Vandendoorent B; Nieuwenhuys A; Jaspers E; Hunaerts C; Desloovere K
Gait Posture; 2014 Jan; 39(1):17-22. PubMed ID: 23791154
[TBL] [Abstract][Full Text] [Related]
12. Is an instrumented spasticity assessment an improvement over clinical spasticity scales in assessing and predicting the response to integrated botulinum toxin type a treatment in children with cerebral palsy?
Bar-On L; Van Campenhout A; Desloovere K; Aertbeliën E; Huenaerts C; Vandendoorent B; Nieuwenhuys A; Molenaers G
Arch Phys Med Rehabil; 2014 Mar; 95(3):515-23. PubMed ID: 23994052
[TBL] [Abstract][Full Text] [Related]
13. The relation between spasticity and muscle behavior during the swing phase of gait in children with cerebral palsy.
Bar-On L; Molenaers G; Aertbeliën E; Monari D; Feys H; Desloovere K
Res Dev Disabil; 2014 Dec; 35(12):3354-64. PubMed ID: 25240217
[TBL] [Abstract][Full Text] [Related]
14. Involuntary and voluntary muscle activation in children with unilateral cerebral palsy--relationship to upper limb activity.
Brændvik SM; Elvrum AK; Vereijken B; Roeleveld K
Eur J Paediatr Neurol; 2013 May; 17(3):274-9. PubMed ID: 23201025
[TBL] [Abstract][Full Text] [Related]
15. Coactivation During Dynamometry Testing in Adolescents With Spastic Cerebral Palsy.
Eken MM; Dallmeijer AJ; Doorenbosch CA; Dekkers H; Becher JG; Houdijk H
Phys Ther; 2016 Sep; 96(9):1438-47. PubMed ID: 26916928
[TBL] [Abstract][Full Text] [Related]
16. Deficits in eccentric versus concentric torque in children with spastic cerebral palsy.
Damiano DL; Martellotta TL; Quinlivan JM; Abel MF
Med Sci Sports Exerc; 2001 Jan; 33(1):117-22. PubMed ID: 11194096
[TBL] [Abstract][Full Text] [Related]
17. Relationships between spasticity, strength, gait, and the GMFM-66 in persons with spastic diplegia cerebral palsy.
Ross SA; Engsberg JR
Arch Phys Med Rehabil; 2007 Sep; 88(9):1114-20. PubMed ID: 17826455
[TBL] [Abstract][Full Text] [Related]
18. Spastic velocity threshold constrains functional performance in cerebral palsy.
Tuzson AE; Granata KP; Abel MF
Arch Phys Med Rehabil; 2003 Sep; 84(9):1363-8. PubMed ID: 13680575
[TBL] [Abstract][Full Text] [Related]
19. [Efficacy and safety of botulinum toxin type A (IncobotulinumtoxinA) in the treatment of patients with cerebral palsy].
Kurenkov AL; Klochkova OA; Bursagova BI; Karimova HM; Kuzenkova LM; Mamedyarov AM; Namazova-Baranova LS; Agranovich OV; Agranovich AO; Soboleva OA; Khapaeva MM; Batysheva TT; Sarzhina MN
Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(11):37-44. PubMed ID: 29265085
[TBL] [Abstract][Full Text] [Related]
20. Relation between spasticity and strength in individuals with spastic diplegic cerebral palsy.
Ross SA; Engsberg JR
Dev Med Child Neurol; 2002 Mar; 44(3):148-57. PubMed ID: 12005315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
